Lördag 21 December | 19:58:59 Europe / Stockholm

Kalender

Tid*
2025-05-23 N/A Årsstämma
2025-02-21 16:00 Bokslutskommuniké 2024
2024-11-08 - Kvartalsrapport 2024-Q3
2024-08-30 - Kvartalsrapport 2024-Q2
2024-08-21 - Extra Bolagsstämma 2024
2024-05-27 - X-dag ordinarie utdelning SDET 0.00 SEK
2024-05-24 - Årsstämma
2024-05-24 - Kvartalsrapport 2024-Q1
2024-02-22 - Bokslutskommuniké 2023
2023-11-30 - Extra Bolagsstämma 2023
2023-11-06 - Kvartalsrapport 2023-Q3
2023-08-28 - Kvartalsrapport 2023-Q2
2023-05-26 - X-dag ordinarie utdelning SDET 0.00 SEK
2023-05-25 - Årsstämma
2023-05-25 - Kvartalsrapport 2023-Q1
2023-02-24 - Bokslutskommuniké 2022
2022-11-11 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-08 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-05-19 - X-dag ordinarie utdelning SDET 0.00 SEK
2022-02-25 - Bokslutskommuniké 2021
2021-11-23 - Kvartalsrapport 2021-Q3
2021-08-31 - Kvartalsrapport 2021-Q2
2021-05-20 - Kvartalsrapport 2021-Q1
2021-05-04 - X-dag ordinarie utdelning SDET 0.00 SEK
2021-05-03 - Årsstämma
2021-02-26 - Bokslutskommuniké 2020
2020-11-27 - Kvartalsrapport 2020-Q3
2020-08-28 - Kvartalsrapport 2020-Q2
2020-06-30 - X-dag ordinarie utdelning SDET 0.00 SEK
2020-06-29 - Årsstämma
2020-05-04 - Kvartalsrapport 2020-Q1
2020-02-17 - Bokslutskommuniké 2019
2019-11-11 - Kvartalsrapport 2019-Q3
2019-08-19 - Kvartalsrapport 2019-Q2
2019-08-15 - Extra Bolagsstämma 2019
2019-05-13 - Kvartalsrapport 2019-Q1
2019-05-03 - X-dag ordinarie utdelning SDET 0.00 SEK
2019-05-02 - Årsstämma
2019-02-12 - Bokslutskommuniké 2018
2018-11-12 - Kvartalsrapport 2018-Q3
2018-08-20 - Kvartalsrapport 2018-Q2
2018-05-11 - Kvartalsrapport 2018-Q1
2018-05-03 - X-dag ordinarie utdelning SDET 0.00 SEK
2018-05-02 - Årsstämma
2018-02-19 - Bokslutskommuniké 2017
2017-11-13 - Kvartalsrapport 2017-Q3
2017-08-21 - Kvartalsrapport 2017-Q2
2017-05-16 - X-dag ordinarie utdelning SDET 0.00 SEK
2017-05-15 - Årsstämma
2017-05-12 - Kvartalsrapport 2017-Q1
2017-02-20 - Bokslutskommuniké 2016
2016-11-14 - Kvartalsrapport 2016-Q3
2016-08-22 - Kvartalsrapport 2016-Q2
2016-06-20 - X-dag ordinarie utdelning SDET 0.00 SEK
2016-06-17 - Årsstämma
2016-05-19 - Kvartalsrapport 2016-Q1
2016-02-22 - Bokslutskommuniké 2015
2015-11-16 - Kvartalsrapport 2015-Q3
2015-08-24 - Kvartalsrapport 2015-Q2
2015-06-04 - X-dag ordinarie utdelning SDET 0.00 SEK
2015-06-03 - Årsstämma
2015-05-12 - Kvartalsrapport 2015-Q1
2015-02-26 - Bokslutskommuniké 2014
2014-11-07 - Kvartalsrapport 2014-Q3
2014-08-28 - Kvartalsrapport 2014-Q2
2014-06-04 - X-dag ordinarie utdelning SDET 0.00 SEK
2014-06-03 - Årsstämma
2014-05-28 - Kvartalsrapport 2014-Q1
2014-02-26 - Bokslutskommuniké 2013
2013-11-21 - Kvartalsrapport 2013-Q3
2013-08-29 - Kvartalsrapport 2013-Q2
2013-06-18 - X-dag ordinarie utdelning SDET 0.00 SEK
2013-06-17 - Årsstämma
2013-05-17 - Kvartalsrapport 2013-Q1
2013-04-03 - 15-7 2013
2013-03-13 - Extra Bolagsstämma 2013
2013-01-28 - Bokslutskommuniké 2012
2012-11-22 - Kvartalsrapport 2012-Q3
2012-08-29 - Kvartalsrapport 2012-Q2
2012-05-23 - Kvartalsrapport 2012-Q1
2012-03-08 - X-dag ordinarie utdelning SDET 0.00 SEK
2012-03-07 - Årsstämma
2012-02-06 - Bokslutskommuniké 2011
2011-11-24 - Kvartalsrapport 2011-Q3
2011-08-25 - Kvartalsrapport 2011-Q2
2011-05-13 - X-dag ordinarie utdelning SDET 0.00 SEK
2011-05-12 - Årsstämma
2011-05-05 - Kvartalsrapport 2011-Q1
2011-02-07 - Bokslutskommuniké 2010
2010-05-07 - X-dag ordinarie utdelning SDET 0.00 SEK

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
SensoDetect är verksamt inom hälsovårdssektorn. Bolaget är specialiserade inom utveckling av medicinsk utrustning som används för att analysera hur en patients hjärna reagerar på ljudstimulans. Tekniken används inom psykiatrin för att urskilja potentiella psykiska sjukdomar. Produkten består av elektroder som fästs på patientens huvud som sedan analyserar hjärnaktiviteten. Resultaten jämförs mot en databas för vidare analys. SensoDetect grundades 2005 och har sitt huvudkontor i Lund.
2024-05-27 08:30:00

As a gateway for the continued work in SensoDetect addressing medical issues, writing, and reviewing educational materials, establish research funding, identify fundraising opportunities and act as prominent ambassadors worldwide for the SensoDetect's method, the company has appointed expert Medical Doctors, Dr Saleh of Saudi Arabia and Dr Löfström of Sweden as medical advisors.

"Our advisory board provides strategic advice and expertise to all situations in our organization. As experienced and trusted advisors they will support our vision and guide SensoDetect in the right direction. As our goal is to advance health equity in part through expanding our offer, our method and provide access to people, all people wherever they live, it's critical to achieve a transformation in different geographical areas with advancement in technology and to capitalize on knowledge from inside to outside of the company. To ensure this our medical advisory board will apply their knowledge in a way that protects patient health in a wider perspective while continuing to support innovation of our invention and method", says CEO Per-Anders (PA) Hedin. 

About our Medicinal Advisory Board.

Dr. Löfström has authored 40 published papers and clinical works. He initially conducted brain research at the Karolinska Institute in Stockholm, where he earned his PhD in 1977. Dr. Löfström received his medical and clinical training at the University hospitals in Lund and Malmö, obtaining his MD in 1986 and becoming a specialist in Child and Youth Psychiatry in 1991. He studied analytical psychology at the Jung Institute in Küsnacht, Switzerland, near Zürich, during the following years. Soon after he started his own psychiatric clinic in Lund, where he has been working with the diagnosis and treatment of neuropsychiatric conditions such as ADHD and, more recently, autism.

Dr. Saleh is a seasoned healthcare leader with extensive experience in health system operations and hospital transformation. He has a distinguished track record in establishing and leading healthcare services at various levels, from primary to tertiary care, across different regions in Saudi Arabia. Dr. Saleh serves as a member of the Prince Mohammed Bin Salman Autism Program Development Scientific Committee at Armed Forces Health Services, where he is responsible for healthcare services aligned with Saudi Vision 2030. He is also a Clinical Assistant Professor at Princess Nourah Bint Abdulrahman University (PNU) School of Medicine and has academic affiliations with King Saud University and King Saud bin Abdulaziz University for Health Sciences.

As the founder and Director of the Child Health Excellence Center at King Abdullah Bin Abdulaziz University Hospital (KAAUH) at PNU, Dr. Saleh plays a pivotal role in advancing pediatric healthcare. He is a CBAHI Hospital Surveyor and contributed to the 2022 revision of the V4 hospital leadership and quality chapter. Additionally, he is the STL for home healthcare, a member of the Autism Services Accreditation Program Committee, and the Chairman of the National Developmental Disorders Scientific Committee under the Saudi Health Council (SHC). Dr. Saleh also chairs the newly established SCFHS fellowship in developmental and behavioral pediatrics and the National Autism Registry Scientific Committee. Furthermore, he founded Ruaa Home Health Care Service, enhancing healthcare access and quality for patients at home.